Perrigo (NYSE: PRGO) revenue
Perrigo reported revenue of $4,253m for fiscal 2025, 2.8% less than in fiscal 2024 ($4,373m). Since fiscal 2016 its revenue has fallen by 19.5%, an average decline of 2.4% a year.
Perrigo's revenue has fallen for 2 years in a row, and its best year of the last 10 was fiscal 2016. The biggest drop was in fiscal 2019, −18.2%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $4,253m | −2.8% | −$1,122m | −26.4% |
| 2024 | $4,373m | −6.1% | $112.9m | 2.6% |
| 2023 | $4,656m | +4.6% | $151.9m | 3.3% |
| 2022 | $4,452m | +7.6% | $78.9m | 1.8% |
| 2021 | $4,139m | +1.2% | $410.4m | 9.9% |
| 2020 | $4,088m | +5.6% | $265.2m | 6.5% |
| 2019 | $3,870m | −18.2% | $174.7m | 4.5% |
| 2018 | $4,732m | −4.3% | $236.5m | 5.0% |
| 2017 | $4,946m | −6.3% | $598.2m | 12.1% |
| 2016 | $5,281m | — | −$2,000m | −37.9% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Perrigo revenue compared with its sector
By revenue for its latest fiscal year, Perrigo ranks 69th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Perrigo, −2.8%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 67th | IDEXX Laboratories | $4,304m | 10.4% |
| 68th | Jazz Pharmaceuticals | $4,268m | 4.9% |
| 69th | Perrigo | $4,253m | −2.8% |
| 70th | Cooper Companies | $4,092m | 5.1% |
| 71st | Align Technology | $4,035m | 0.9% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Perrigo
- How much revenue did Perrigo make in fiscal 2025?
- Perrigo reported revenue of $4,253m for fiscal 2025, compared with $4,373m in fiscal 2024.
- How much has the revenue of Perrigo fallen?
- Between fiscal 2016 and fiscal 2025 it went from $5,281m to $4,253m: 19.5% less, an average decline of 2.4% a year.
- What was the best year for revenue at Perrigo?
- Of its last 10 fiscal years, fiscal 2016, with $5,281m.
- Where does Perrigo rank in its sector by revenue?
- It ranks 69th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Perrigo come from?
- From the annual report (Form 10-K) that Perrigo files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Perrigo files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Perrigo: the Perrigo page · annual accounts · net income · dividends paid · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.